Dublin, Nov. 01, 2021 (GLOBE NEWSWIRE) -- The "Transdermal Drug Patches to 2028" report has been added to ResearchAndMarkets.com's offering.
Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver.
Advances in synthetic materials and patch design have led to patches that are more aesthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package.
Growth in demand for drug patches is being driven by several factors - factors with strong demographic and population trend underpinnings.
Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2028.
What You Will Learn
Analyzes and evaluates current transdermal drug patch markets and products and assesses the market potential for existing and probable future products
Analyzes patch designs, technologies and patch development issues
Profiles patch manufacturers and third-party transdermal supply chain companies
Provides detailed assessments of more than forty patch products in more than a dozen product categories
Provides market data and forecasts to 2028
Profiles transdermal drug patch product providers, their product development activity, and strategies
Evaluates the impact of economic, technology, and regulatory factors
Key Topics Covered:
The Market Opportunity
Transdermal Drug Delivery Dynamics
Factors Limiting Growth
Pharmacokinetics & Dosage Forms
Patch Manufacturing Dynamics
Patch Manufacturing Company Profiles
Product Analysis -
FDA-Approved Drugs Delivered via Transdermal Patches
Development-stage Drug Patches
Market Analysis - Transdermal Drug Patch Therapeutics
Hormone Replacement Therapy
IP and Expiring Patents
Patient Compliance and Ease of Use
Aveva Drug Delivery Systems
Lohmann Therapie Systems
For more information about this report visit https://www.researchandmarkets.com/r/sxaqu4
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900